One of Indiaβs largest pharmaceutical company, Glenmark Pharma, reported their net consolidated profit for the June-end quarter of the current fiscal year at Rs. 232.99...
Sun Pharmaceutical IndustriesΒ wholly owned subsidiaries has launched generic metformin hydrochloride extended release tablets, used for glycemic control, in the US market. The tablets are generic...
Zydus Cadila has received final approvals from the US health regulator, to market four generic products in America. TheΒ approvals received are forΒ Olanzapine tablets in strengths...
Lupin has received final approval from the US health regulator, for itsΒ Oseltamivir Phosphate. In a BSE filing the company stated that, it has received final...
Lupin has launched genericΒ Oseltamivir Phosphate capsules, in the US market which is used fro treating influenza. In a BSE filing the company stated that, it...
Lupin for treating serious infections has launched Flucytosine capsules, in the American market. In a regulatory filing, Lupin stated that, the company has launched its...
Cipla’s subsidiary InvaGen Pharmaceuticals Inc has received nod from the US health regulator forΒ Sevelamer Carbonate tablets,Β which are suggested for the control of serum phosphorus in...
Sun Pharmaceuticals Industries subsidiary receives nod from the US health regulator to market generic version of GSK’s Coreg CR,extended release capsules in the American market....
Panacea Biotec hasΒ declaredΒ the launch of generic version of anti-platelet medication Prasugrel 5mg and 10mgΒ tablets in US. Panacea’sΒ Prasugrel copies are first to file abbreviated new...
Glenmark Pharmaceuticals has got an approval from US health regulator to market Desonide Ointment, to treat skin problems,in the American market. According to company’s statement,...